Glial cell abnormalities in major psychiatric disorders: the evidence and implications
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) logged adverse reactions to Melanotan II and warned the public of serious health risks. The UK agency is also concerned that MT-II is increasingly being marketed to younger consumers with bright colors and branding and has been focused on removing UK-facing sales websites advertising MT-II since 2011
Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL Efficacy of metformin in type II diabetes: Results of a double-blind, placebo-controlled, dose-response trial
During OA, subchondral bone thickens and osteophytes form
Rhonda has been in the addictions and mental health recovery field for nearly 20 years
Nocturnal hypoglycaemia can cause sleep disruption, night sweats, and vivid dreams